Skip to main content
. 2020 Jun 9;12(6):529. doi: 10.3390/pharmaceutics12060529

Table 1.

Intrabodies against neurodegenerative diseases.

Alzheimer’s Disease Target: β-amyloid Protein
Antigen Species Intrabody Experimental Phase Reference(s)
Aβ1–42 scFv scFvAβIB Preclinical in mice [8]
scFv Aβ-scFv Preclinical in mice [9]
Parkinson’s Disease Target: α-synuclein Protein
Antigen Species Intrabody Experimental Phase Reference(s)
Oligomeric α-synuclein Human scFv D5 Preclinical in mice [10,11,12,13]
Oligomeric α-synuclein Human scFv 10H Preclinical in mice [10,12,14]
Pan-specific α-synuclein Human scFv D10 Preclinical in mice [10,12,15]
Hydrophobic non-amyloid component (NAC) of α-synuclein, AA53–95 Human nanobody (VH) VH14 (NAC14) Preclinical in rats [10,16,17]
α-synuclein AA53–87 Human scFv NAC32 In vitro in cell culture [17]
Fibrillar α-synuclein Human scFv 6E In vitro in cell culture [11,18]
α-synuclein, AA118–131 Camelid nanobody (VHH) Nbsyn2 In vitro in cell culture [16,19]
α-synuclein, AA137-140 Camelid nanobody (VHH) Nbsyn87 Preclinical in rats [16,19,20]
Huntington’s Disease Target: Huntingtin (HTT) Protein
Antigen Species Intrabody Experimental Phase Reference(s)
HTT-N17 (PolyQ N-term AA1-17) Human scFv scFvC4 Preclinical in mice [11,21,22,23,24,25,26,27,28,29,30]
HTT-N20 (PolyQ N-term, AA1-20) Human VL VL12.3 Preclinical in mice [22,31,32,33,34,35]
HTT-polyQ Mouse scFv MW1 In vitro in cell culture [36,37]
HTT-polyQ Mouse scFv MW2 In vitro in cell culture [36,37]
HTT-PRR Mouse scFv MW7 Ex vivo in brain tissue [33,36,37]
HTT-PRR Human VL Happ1 Preclinical in mice [33,34]
HTT-PRR Human VL Happ3 Ex vivo in brain tissue [33]
HTT-Exon1 Mouse scFv EM48 Preclinical in mice [38]
HTT-PRR Human scFv INT41 Preclinical in mice [39]
Fibrillar mHTT Human scFv 6E In vitro in cell culture [18,21]
Amyotrophic Lateral Sclerosis (ALS) Disease Target: SOD1 Protein
Antigen Species Intrabody Experimental Phase Reference(s)
SOD1 Human scFv B1 Preclinical in mice [40,41]
SOD1 Human scFv B12 Preclinical in mice [40,41]
G93A human SOD1 Mouse scFv D3H5 Preclinical in mice [42]
Prion Disorder Target: Prion Protein (PrP)
Antigen Species Intrabody Experimental Phase Reference(s)
Cellular PrP Mouse scFv 8H4 Preclinical in mice [43,44]
Cellular PrP Mouse scFv 8F9 In vitro in cell culture [43]
Cellular PrP Camelid nanobody (VHH) Nb_PrP_01 In vitro in crystallography studies [45,46]
Cellular PrP AA123–125, 164–170, and 174–185 Camelid nanobody (VHH) Nb484 In vitro in crystallography studies [46]